Analysed VIATRIS INC (VTRS:NASDAQ) News Sources
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
16-10-2026
yahoo.com
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Viatris (NASDAQ:VTRS) Vs The Rest Of The Pack
21-10-2026
yahoo.com
Pacira BioSciences (PCRX) Stock Gets Fair Value Boost After Viatris Deal Framing
23-10-2026
yahoo.com
What is the current price of VIATRIS INC (VTRS:NASDAQ)?
The current price of VIATRIS INC (VTRS:NASDAQ) is $19.035.
VIATRIS INC (VTRS:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIATRIS INC (VTRS:NASDAQ) since the previous trading day is $-0.165.
VIATRIS INC (VTRS:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIATRIS INC (VTRS:NASDAQ) since the previous trading day is -0.8594%.
What is the most recent average sentiment score for VIATRIS INC (VTRS:NASDAQ)?
The most recent average sentiment score for VIATRIS INC (VTRS:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for VIATRIS INC (VTRS:NASDAQ)?
The most recent sentiment for VIATRIS INC (VTRS:NASDAQ) is .
SEC-8K** Filing Available For VIATRIS INC (VTRS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.